New Zealand Pharmaceuticals & Biotech Most Popular Stocks

Results

0 new

Most Popular Stocks on the market

4 companies

AFT Pharmaceuticals

Market Cap: NZ$470.9m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$4.49

4.4%

70.7%

Pacific Edge

Market Cap: NZ$304.3m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.24

-3.9%

71.3%

BLIS Technologies

Market Cap: NZ$25.6m

Develops and sells probiotics in New Zealand, the Asia Pacific, Europe, the Middle East, Africa, and North America.

BLT

NZ$0.02

5.3%

11.1%

Rua Bioscience

Market Cap: NZ$11.9m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.035

6.1%

-39.7%